Allspring Global Investments Holdings LLC Sells 33,161 Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Allspring Global Investments Holdings LLC reduced its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 10.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 284,547 shares of the company’s stock after selling 33,161 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.45% of Guardian Pharmacy Services worth $6,049,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Brown Advisory Inc. acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at approximately $32,294,000. Geode Capital Management LLC acquired a new position in Guardian Pharmacy Services during the 4th quarter worth approximately $4,073,000. Renaissance Technologies LLC bought a new position in Guardian Pharmacy Services in the 4th quarter valued at approximately $2,859,000. Royce & Associates LP lifted its stake in Guardian Pharmacy Services by 185.3% in the 4th quarter. Royce & Associates LP now owns 214,000 shares of the company’s stock valued at $4,336,000 after purchasing an additional 139,000 shares during the last quarter. Finally, Northern Trust Corp acquired a new stake in Guardian Pharmacy Services in the fourth quarter valued at approximately $1,479,000.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on GRDN. Raymond James Financial set a $28.00 price target on shares of Guardian Pharmacy Services and gave the stock an “outperform” rating in a report on Wednesday, May 14th. Wall Street Zen cut Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Finally, Truist Financial reiterated a “buy” rating and issued a $28.00 target price (up from $25.00) on shares of Guardian Pharmacy Services in a research report on Monday, May 19th.

Insider Transactions at Guardian Pharmacy Services

In related news, Director William E. Bindley sold 651,454 shares of Guardian Pharmacy Services stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total value of $13,133,312.64. Following the completion of the sale, the director owned 1,939,817 shares of the company’s stock, valued at approximately $39,106,710.72. This trade represents a 25.14% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director John Ackerman sold 201,303 shares of the stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total value of $4,058,268.48. Following the completion of the sale, the director directly owned 149,794 shares of the company’s stock, valued at approximately $3,019,847.04. This trade represents a 57.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,344,912 shares of company stock worth $228,713,426. 63.71% of the stock is currently owned by insiders.

Guardian Pharmacy Services Stock Performance

Shares of NYSE GRDN opened at $20.85 on Friday. Guardian Pharmacy Services, Inc. has a 52-week low of $14.16 and a 52-week high of $26.91. The firm has a 50 day moving average price of $22.37 and a two-hundred day moving average price of $21.50.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.01). The company had revenue of $329.31 million for the quarter, compared to the consensus estimate of $321.21 million. On average, equities analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.